Skip to content
Wednesday, July 06, 2022
Today's Neurologist

Today's Neurologist

Neurology Updates

Today's Neurologist
  • Latest News
  • Conditions
    • Autism Spectrum Disorder
    • Alzheimer’s disease and dementia
    • Pain
    • Neurocognitive Disorders
    • Movement Disorders
    • Neurodegenerative
    • Epilepsy
    • Headache
    • General Neurology
    • Sleep Disorders
    • Stroke
    • Brain Tumors
    • Multiple Sclerosis
    • Seizure Disorders
    • Neuromuscular Disorders
    • Neurobehavioral Disorders
    • Pediatric Neurology
    • Traumatic Brain Injury
    • Vascular Neurology
  • Drug updates
  • Practice Management
  • Cases
  • Resources
    • Neurological Exams
  • Our Team
Today's Neurologist
  • About Us
  • Our Team
  • Privacy Policy

Latest News

Drug updates Latest News Multiple Sclerosis

New MAMS Adaptive Trial Shows Promise for Future Progressive MS Treatments

Fardin Nabizadeh May 1, 2022

Clinical trials have produced remarkable strides in the treatment of multiple sclerosis (MS) in recent decades, especially for patients with the relapsing-remitting form of the…

Drug updates Latest News Multiple Sclerosis

Hydroxychloroquine Delays Disability for Least Treatable Form of Multiple Sclerosis

Fardin Nabizadeh January 20, 2022 No Comments

Hydroxychloroquine shows promise for reducing some of the debilitating systems associated with primary progressive multiple sclerosis, a new study reports. A University of Calgary study…

General Neurology Latest News

Plasma Tau as associated with Neurocognitive Impairment in Pediatric Malaria

Fardin Nabizadeh January 20, 2022

Plasma tau, which indicates injury to neuronal axons, is higher among children with cerebral malaria (CM) and severe malarial anemia (SMA), according to study findings…

Latest News Movement Disorders Neurodegenerative

Disrupted connectivity in Parkinson’s disease (PD) with the probable Rapid eye movement behavior disorder ( RBD)

Fardin Nabizadeh January 5, 2022 No Comments

Rapid eye movement sleep behavior disorder ( RBD) is a kind of sleep disorder in which a person experiences some physical movements and unpleasant dreams…

Latest News Pain

Dangerous Microbe Offer a New Way to Silence Pain

Fardin Nabizadeh December 23, 2021

A specific anthrax toxin blocks multiple types of pain in mouse models, a new study reports Anthrax has a scary reputation. Widely known to cause…

Tag: FDA

Latest News Pain Practice Management

FDA Approves Virtual Reality System to Ease Back Pain

Fardin Nabizadeh November 22, 2021 FDAneurologistNeurologyNeuroscience Newstoday's neurologistVirtual Reality

HealthDay News — A three-dimensional (3-D) virtual reality system to treat back pain was approved by the U.S. Food and Drug Administration on Tuesday. The EaseVRx…

View More FDA Approves Virtual Reality System to Ease Back Pain

Drug updates

Drug updates Latest News Multiple Sclerosis

New MAMS Adaptive Trial Shows Promise for Future Progressive MS Treatments

Fardin Nabizadeh May 1, 2022

Clinical trials have produced remarkable strides in the treatment of multiple sclerosis (MS) in recent decades, especially for patients with the relapsing-remitting form of the…

Drug updates Latest News Multiple Sclerosis

Hydroxychloroquine Delays Disability for Least Treatable Form of Multiple Sclerosis

Fardin Nabizadeh January 20, 2022 No Comments

Hydroxychloroquine shows promise for reducing some of the debilitating systems associated with primary progressive multiple sclerosis, a new study reports. A University of Calgary study…

Drug updates General Neurology Latest News

Cabozantinib Shows Promise for Renal Cell Carcinoma With Brain Metastases

Fardin Nabizadeh December 1, 2021

Cabozantinib yields promising intracranial activity with an acceptable safety profile for patients who developed brain metastases from renal cell carcinoma (RCC), according to study results…

Alzheimer's disease and dementia Drug updates Latest News Neurocognitive Disorders

Methylphenidate Safe and Effective in Reducing Apathy in Alzheimer Disease

Fardin Nabizadeh November 4, 2021

Methylphenidate, the most widely studied catecholaminergic compound in older adults, is safe and may have modest but noticeable benefits on apathy in patients with Alzheimer…

Drug updates Latest News Multiple Sclerosis Neurodegenerative Practice Management

Long-Term Satralizumab Safe in Patients with Neuromyelitis Optica Spectrum Disorder

Fardin Nabizadeh October 27, 2021

The following article is part of conference coverage from the 2021 Annual Meeting of the Consortium of Multiple Sclerosis Centers (CMSC), held October 25-28 2021, in…

Practice management

Latest News Pain Practice Management

FDA Approves Virtual Reality System to Ease Back Pain

Fardin Nabizadeh November 22, 2021

HealthDay News — A three-dimensional (3-D) virtual reality system to treat back pain was approved by the U.S. Food and Drug Administration on Tuesday. The EaseVRx…

Latest News Multiple Sclerosis Neurodegenerative Practice Management

Exercise Therapy Has Positive Effect on Multiple Sclerosis-Related Fatigue

Fardin Nabizadeh November 22, 2021

Exercise is an effective therapeutic strategy for fatigue in patients with multiple sclerosis (MS), and combined exercise is the most effective modality for physical and…

Latest News Neurodegenerative Practice Management

Huntington Disease May Be Undertreated and Current Monotherapies Inadequate

Fardin Nabizadeh November 15, 2021

A minority of individuals with chorea are receiving anti-chorea medication, which suggests that Huntington’s disease may be undertreated, according to research recently presented at Psych…

General Neurology Latest News Practice Management

The Path to Diversity and Inclusion in Neurology: Virtual Residency Recruitment

Fardin Nabizadeh November 8, 2021

In the US, a country where ethnic minorities continue to be burdened by disparities in health care access, disease incidence, and morbidity, an ethnically diverse…

Epilepsy Latest News Practice Management

Transcutaneous Auricular Vagus Nerve Stimulation Offers Modest Feasibility for Epilepsy

Fardin Nabizadeh October 27, 2021

Transcutaneous auricular vagus nerve stimulation (taVNS), a novel self-care technique to noninvasively stimulate the vagus nerve as a treatment option for drug-resistant epilepsy, had a…

Today's Neurologist | Designed by: Theme Freesia | WordPress | © Copyright All right reserved